Belle Capital

TO THE MARKET is a company focused on the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and headquartered in the United States, it serves artisan groups and suppliers globally. The company operates as an ethical supply chain platform, providing comprehensive solutions that encompass design, production, compliance, sourcing, logistics, and reporting. TO THE MARKET caters to major corporations seeking transparency in their supply chains, offering proprietary tools for vendor evaluation, procurement workflows, and automated reporting. Through its services, the company enables retailers to gather quantifiable data on their suppliers' impact, thereby supporting sustainability and supply chain transparency efforts without compromising on speed and innovation.

TO THE MARKET is a company focused on the ethical manufacturing and sourcing of apparel, accessories, and home goods. Established in 2016 and headquartered in the United States, it serves artisan groups and suppliers globally. The company operates as an ethical supply chain platform, providing comprehensive solutions that encompass design, production, compliance, sourcing, logistics, and reporting. TO THE MARKET caters to major corporations seeking transparency in their supply chains, offering proprietary tools for vendor evaluation, procurement workflows, and automated reporting. Through its services, the company enables retailers to gather quantifiable data on their suppliers' impact, thereby supporting sustainability and supply chain transparency efforts without compromising on speed and innovation.

Ocuphire Pharma, Inc. is a clinical-stage biopharmaceutical company based in Farmington Hills, Michigan, dedicated to developing and commercializing therapies for various ophthalmic disorders. The company's primary focus is on innovative treatment options for front and back of the eye conditions, with its lead product candidate, Nyxol eye drops, currently in Phase 3 clinical development. Nyxol is a once-daily, preservative-free formulation aimed at addressing issues such as dim light or night vision disturbances, pharmacologically-induced mydriasis, and presbyopia. Additionally, Ocuphire is advancing another candidate, APX3330, a twice-daily oral tablet, which is entering Phase 2 clinical trials to target diabetic retinopathy and diabetic macular edema by inhibiting angiogenesis and inflammation. The company also seeks to explore opportunities for acquiring additional ophthalmic assets and forming strategic partnerships for global commercialization.

Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.

Joylux, Inc. is a health and wellness company based in Seattle, Washington, specializing in women's health solutions. Founded in 2013, the company develops LED-focused medical devices aimed at addressing pelvic-floor issues and enhancing vaginal health. Joylux offers an at-home pelvic-floor toning and vaginal rejuvenation device that employs photobiomodulation technology to alleviate symptoms associated with genitourinary syndrome of menopause. The company is dedicated to providing noninvasive, effective, and affordable products that improve various aspects of women's intimate health, while also focusing on collecting health data to help women better predict and manage their symptoms during menopause.

Digsite, Inc. is a company that has developed a SaaS platform for online insight communities, enhancing traditional online focus groups. Founded in 2014 and based in Madison, Wisconsin, the platform allows moderators to initiate discussions, upload multimedia content, and utilize various survey tools, enabling participants to contribute their insights. Designed for marketers, researchers, and agencies, Digsite facilitates rapid consumer engagement for the development and refinement of product concepts, marketing strategies, and customer experiences. The platform mimics familiar social media interfaces, allowing for quick setup of research communities with up to 100 participants in a single day. It incorporates advanced automation to streamline participant recruitment and management, while also offering proprietary tools for conversation management, survey creation, and multimedia capture. Additionally, Digsite's SmartReporting feature brings qualitative research findings to life, supporting better and faster business decisions through effective analysis of customer insights.

CardiaLen, Inc. is a medical device company based in Minneapolis, Minnesota, specializing in the development of innovative therapies for atrial fibrillation and other heart arrhythmias. Founded in 2008, the company is focused on creating implantable, low-energy cardioverter devices that offer pain-free cardioversion therapies. These devices monitor the heartbeat and employ a proprietary series of low-energy pulses to restore normal heart rhythm while minimizing discomfort and preventing damage to heart tissue. By addressing significant unmet needs in the treatment of atrial fibrillation, CardiaLen aims to enhance patient outcomes and reduce reliance on high-energy defibrillation shocks.

Current Motor Company is based in Ann Arbor, Michigan, and specializes in the development and manufacture of electric motor scooters aimed at urban commuters. The company produces all-electric maxi-scooters that are designed to be fast, fun, and affordable, offering zero-emission transportation solutions. These maxi-scooters can reach speeds of up to 70 MPH and have a range of up to 50 miles, charging conveniently from a standard 110V outlet in approximately five hours. Current Motor sells and services its products through a network of dealers and has formed a strategic partnership with Dakkota Integrated Systems. The company is supported by various investors, including BELLE Capital and the State of Michigan.